Cargando…
Sedation improves early outcome in severely septic Sprague Dawley rats
INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750194/ https://www.ncbi.nlm.nih.gov/pubmed/19691839 http://dx.doi.org/10.1186/cc8012 |
_version_ | 1782172224611942400 |
---|---|
author | Qiao, Hong Sanders, Robert D Ma, Daqing Wu, Xinmin Maze, Mervyn |
author_facet | Qiao, Hong Sanders, Robert D Ma, Daqing Wu, Xinmin Maze, Mervyn |
author_sort | Qiao, Hong |
collection | PubMed |
description | INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to patients randomized to a benzodiazepine-based sedative regimen. We sought to compare the effects of dexmedetomidine and midazolam, at equi-sedative doses, on inflammation and apoptosis in an animal model of severe sepsis. METHODS: After central venous access, Sprague Dawley rats underwent cecal ligation and intestinal puncture (CLIP) with an 18 G needle without antibiotic cover and received either saline, or an infusion of comparable volume of saline containing midazolam (0.6 mg.kg-1.h-1) or dexmedetomidine (5 ug.kg-1.h-1) for 8 hours. Following baseline measurements and CLIP, blood was sampled for cytokine measurement (tumour necrosis factor (TNF)-alpha and interleukin (IL)-6; n = 4-6 per group) at 2, 4 and 5 hours, and animal mortality rate (MR) was monitored (n = 10 per group) every 2 hours until 2 hours had elapsed. In addition, spleens were harvested and apoptosis was assessed by immunoblotting (n = 4 per group). RESULTS: The 24 hour MR in CLIP animals (90%) was significantly reduced by sedative doses of either dexmedetomidine (MR = 20%) or midazolam (MR = 30%). While both sedatives reduced systemic levels of the inflammatory cytokine TNF-alpha (P < 0.05); only dexmedetomidine reduced the IL-6 response to CLIP, though this narrowly missed achieving significance (P = 0.05). Dexmedetomidine reduced splenic caspase-3 expression (P < 0.05), a marker of apoptosis, when compared to either midazolam or saline. CONCLUSIONS: Sedation with midazolam and dexmedetomidine both improve outcome in polymicrobial severely septic rats. Possible benefits conveyed by one sedative regimen over another may become evident over a more prolonged time-course as both IL-6 and apoptosis were reduced by dexmedetomidine but not midazolam. Further studies are required to evaluate this hypothesis. |
format | Text |
id | pubmed-2750194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27501942009-09-25 Sedation improves early outcome in severely septic Sprague Dawley rats Qiao, Hong Sanders, Robert D Ma, Daqing Wu, Xinmin Maze, Mervyn Crit Care Research INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to patients randomized to a benzodiazepine-based sedative regimen. We sought to compare the effects of dexmedetomidine and midazolam, at equi-sedative doses, on inflammation and apoptosis in an animal model of severe sepsis. METHODS: After central venous access, Sprague Dawley rats underwent cecal ligation and intestinal puncture (CLIP) with an 18 G needle without antibiotic cover and received either saline, or an infusion of comparable volume of saline containing midazolam (0.6 mg.kg-1.h-1) or dexmedetomidine (5 ug.kg-1.h-1) for 8 hours. Following baseline measurements and CLIP, blood was sampled for cytokine measurement (tumour necrosis factor (TNF)-alpha and interleukin (IL)-6; n = 4-6 per group) at 2, 4 and 5 hours, and animal mortality rate (MR) was monitored (n = 10 per group) every 2 hours until 2 hours had elapsed. In addition, spleens were harvested and apoptosis was assessed by immunoblotting (n = 4 per group). RESULTS: The 24 hour MR in CLIP animals (90%) was significantly reduced by sedative doses of either dexmedetomidine (MR = 20%) or midazolam (MR = 30%). While both sedatives reduced systemic levels of the inflammatory cytokine TNF-alpha (P < 0.05); only dexmedetomidine reduced the IL-6 response to CLIP, though this narrowly missed achieving significance (P = 0.05). Dexmedetomidine reduced splenic caspase-3 expression (P < 0.05), a marker of apoptosis, when compared to either midazolam or saline. CONCLUSIONS: Sedation with midazolam and dexmedetomidine both improve outcome in polymicrobial severely septic rats. Possible benefits conveyed by one sedative regimen over another may become evident over a more prolonged time-course as both IL-6 and apoptosis were reduced by dexmedetomidine but not midazolam. Further studies are required to evaluate this hypothesis. BioMed Central 2009 2009-08-19 /pmc/articles/PMC2750194/ /pubmed/19691839 http://dx.doi.org/10.1186/cc8012 Text en Copyright ©2009 Qiao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Qiao, Hong Sanders, Robert D Ma, Daqing Wu, Xinmin Maze, Mervyn Sedation improves early outcome in severely septic Sprague Dawley rats |
title | Sedation improves early outcome in severely septic Sprague Dawley rats |
title_full | Sedation improves early outcome in severely septic Sprague Dawley rats |
title_fullStr | Sedation improves early outcome in severely septic Sprague Dawley rats |
title_full_unstemmed | Sedation improves early outcome in severely septic Sprague Dawley rats |
title_short | Sedation improves early outcome in severely septic Sprague Dawley rats |
title_sort | sedation improves early outcome in severely septic sprague dawley rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750194/ https://www.ncbi.nlm.nih.gov/pubmed/19691839 http://dx.doi.org/10.1186/cc8012 |
work_keys_str_mv | AT qiaohong sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats AT sandersrobertd sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats AT madaqing sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats AT wuxinmin sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats AT mazemervyn sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats |